Found: 18
Select item for more details and to access through your institution.
The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.
- Published in:
- EMBO Reports, 2005, v. 6, n. 3, p. 275, doi. 10.1038/sj.embor.7400352
- By:
- Publication type:
- Article
Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44<sup>+</sup> Gastric Cancer Stem Cells.
- Published in:
- Stem Cells Translational Medicine, 2017, v. 6, n. 3, p. 819, doi. 10.1002/sctm.16-0335
- By:
- Publication type:
- Article
Systemic Therapy of Cholangiocarcinoma.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 6, p. 427, doi. 10.1159/000453084
- By:
- Publication type:
- Article
Future Therapy of Cholangiocarcinoma.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 6, p. 431, doi. 10.1159/000450720
- By:
- Publication type:
- Article
Capsaicin Treatment Attenuates Cholangiocarcinoma Carcinogenesis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095605
- By:
- Publication type:
- Article
Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 <i>In Vivo</i>.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077433
- By:
- Publication type:
- Article
Epithelial Mesenchymal Transition and Pancreatic Tumor Initiating CD44+/EpCAM+ Cells Are Inhibited by c-Secretase Inhibitor IX.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0046514
- By:
- Publication type:
- Article
Author Correction: The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 615, doi. 10.3390/cancers12030615
- By:
- Publication type:
- Article
Targeting interleukin 6 signaling by monoclonal antibody siltuximab on cholangiocarcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 5, p. 1334, doi. 10.1111/jgh.15307
- By:
- Publication type:
- Article
Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 4, p. 859, doi. 10.1093/carcin/bgt394
- By:
- Publication type:
- Article
Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines.
- Published in:
- International Journal of Oncology, 2016, v. 48, n. 5, p. 2025, doi. 10.3892/ijo.2016.3411
- By:
- Publication type:
- Article
Correction: Capsaicin Treatment Attenuates Cholangiocarcinoma Carcinogenesis.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma.
- Published in:
- Molecular Carcinogenesis, 2016, v. 55, n. 12, p. 2037, doi. 10.1002/mc.22449
- By:
- Publication type:
- Article
Early Detection of Hepatocellular Carcinoma: How to Screen and Follow up Patients with Liver Cirrhosis According to the GERMAN S3 Guideline?
- Published in:
- Diagnostics (2075-4418), 2015, v. 5, n. 4, p. 497, doi. 10.3390/diagnostics5040497
- By:
- Publication type:
- Article
Correction: Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development.
- Published in:
- PLoS Medicine, 2008, v. 5, n. 6, p. e123, doi. 10.1371/journal.pmed.0050123
- By:
- Publication type:
- Article
Hepatocellular carcinoma and octreotide: Treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.
- Published in:
- Journal of Gastroenterology & Hepatology, 2005, v. 20, n. 9, p. 1422, doi. 10.1111/j.1440-1746.2005.03959.x
- By:
- Publication type:
- Article